Metronomic Chemotherapy: Looking at A New Way to Receive Treatment
Metronomic chemotherapy is an emerging way of giving chemotherapy that aims to provide less toxicity than traditional chemotherapy. With traditional chemotherapy,...
Read MoreLobular Metastatic Breast Cancer
Lobular breast cancer is breast cancer that starts in the lobes where milk is made, and makes up about 10-15% of invasive breast cancer diagnoses. It is more...
Read MoreFinancial Toxicity: Managing Costs While Enrolled in a Clinical Trial
“Financial toxicity” is related to the problem of the cost of cancer treatment, including costs associated with being in a clinical trial. Even with...
Read MoreWhat are Solid Tumor Trials and Why Are They Important?
Solid tumors are made of a mass of tissue that does not usually contain cysts or areas of liquid. Breast cancer is a type of solid tumor. A solid tumor clinical...
Read MorePrepare For SABCS 2021
San Antonio Breast Cancer Symposium (SABCS) is coming soon (December 7-10, 2021). People living with MBC can attend SABCS and other conferences to learn about the...
Read MoreInflammatory MBC Treatments
Inflammatory breast cancer is rare, making up only 1-5% of cases of breast cancer in the US. Inflammatory breast cancer does not always involve a lump, and...
Read MorePink October/MBC Awareness Day
The “Pink October” that comes with Breast Cancer Awareness Month can be difficult for people living with MBC. Many people living with MBC feel left...
Read MoreSteps Toward Expanding Eligibility Criteria to Increase Diversity in Clinical Trials
Lack of diversity is a long-standing issue in clinical trials. This lack of diversity is often related to strict eligibility criteria, including other medications...
Read MoreMetastatic Breast Cancer News from 2021 ESMO
The European Society for Medical Oncology (ESMO) was held virtually from September 16-21, 2021. Links to MBC-related news from this conference are found below....
Read MoreSEARCH OUR SITE
for past articles or specific information.